首页> 美国卫生研究院文献>The Journal of Neuroscience >Cannabinoid Receptor Activation in the Basolateral Amygdala Blocks the Effects of Stress on the Conditioning and Extinction of Inhibitory Avoidance
【2h】

Cannabinoid Receptor Activation in the Basolateral Amygdala Blocks the Effects of Stress on the Conditioning and Extinction of Inhibitory Avoidance

机译:基底外侧杏仁核中的大麻素受体激活阻滞了应激对抑制性回避条件的抑制和消除

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite the efficacy of behavior therapy for human anxiety disorders, extinction-like treatments require repeated cue exposures and are vulnerable to reversal by a number of environmental factors, particularly stress. The endocannabinoid system has recently emerged as important in the regulation of extinction learning and in the regulation of the hypothalamic–pituitary–adrenal axis. Here, we aimed to examine the involvement of the cannabinoid CB1 receptor in the basolateral amygdala (BLA) in inhibitory avoidance (IA) conditioning and extinction and to test whether cannabinoid activation would reverse the effects of stress on these memory processes. The synthetic full agonist of the CB1/CB2 receptor WIN55,212-2 [R-(+)-(2,3-dihydro-5-methyl-3-[(4-morpholinyl)methyl]pyrol[1,2,3-de]-1,4- benzoxazin-6-yl)(1-naphthalenyl) methanone monomethanesulfonate] (5 μg/0.5 μl) microinjected into the BLA had no effect on IA conditioning or extinction by itself. However, microinjecting WIN55,212-2 into the BLA before exposing the rats to a stressor reversed the enhancing effects of the stressor on IA conditioning and its impairing effects on IA extinction. Importantly, WIN55,212-2 microinjected into the BLA reduced stress-induced elevations in corticosterone levels. Control experiments demonstrated the following: (1) the effects of WIN55,212-2 could not be attributed to sensorimotor deficits, because these parameters seemed unchanged by WIN55,212-2 microinjected into the BLA; and (2) the CB1 receptor in the BLA is crucially involved in the extinction of IA, because the CB1 receptor antagonist AM251 [N-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide] (6 ng/0.5 μl) microinjected into the BLA significantly blocked extinction. Together, our findings may support a wide therapeutic application for cannabinoids in the treatment of conditions associated with the inappropriate retention of aversive memories and stress-related disorders.
机译:尽管行为疗法对人类焦虑症有效,但类似灭绝的疗法仍需要反复暴露线索,并且容易受到许多环境因素(尤其是压力)的逆转。近年来,内源性大麻素系统已在消光学习的调控和下丘脑-垂体-肾上腺轴的调控中发挥了重要作用。在这里,我们旨在检查大麻素CB1受体参与基底外侧杏仁核(BLA)的抑制回避(IA)调节和消光作用,并测试大麻素活化是否会逆转压力对这些记忆过程的影响。 CB1 / CB2受体WIN55,212-2 [R-(+)-(2,3-二氢-5-甲基-3-[(4-吗啉基)甲基]吡咯[1,2,3]微量注入BLA的[-de] -1,4- benzoxazin-6-yl)(1-萘基)甲酮甲磺酸](5μg/ 0.5μl)对IA调节或自身灭绝没有影响。但是,在将大鼠暴露于应激源之前,将WIN55,212-2微注射到BLA中可以逆转应激源对IA调节的增强作用及其对IA消光的削弱作用。重要的是,微注射到BLA中的WIN55,212-2可减少应激引起的皮质酮水平升高。对照实验表明:(1)WIN55,212-2的作用不能归因于感觉运动缺陷,因为通过微注射到BLA中的WIN55,212-2,这些参数似乎没有改变; (2)BLA中的CB1受体至关重要地参与了IA的灭绝,因为CB1受体拮抗剂AM251 [N-1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-微注射到BLA中的N-1-哌啶基-1H-吡唑-3-羧酰胺](6 ng / 0.5μl)明显阻止了灭绝。总之,我们的发现可能支持大麻素在与厌恶记忆力和压力相关疾病的不适当保留相关的疾病的治疗中的广泛治疗应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号